You are here:
Publication details
Predictors of premature withdrawal and dose reduction in patients with chronic hepatitis C treated with Peginterferon alfa-2a (40kD) plus ribavirin in a large, multinational, open-label expanded access program.
Title in English | Predikce předčasného vysazení a redukce dávky PEG-IFN alfa-2a a ribavirinu u nemocných s chronickou hepatitidou C. |
---|---|
Authors | |
Year of publication | 2009 |
Type | Article in Periodical |
Magazine / Source | Hepatology |
MU Faculty or unit | |
Citation | |
Field | Epidemiology, infectious diseases and clinical immunology |